Recent experiments have identified LXRa, a nuclear hormone receptor that binds oxysterols, as a key regulator of hepatic cholesterol homeostasis. The amount of cholesterol in animal cell membranes is tightly regulated to maintain proper cell function. Experiments performed over the past several years have shown that this regulation occurs in large part through transcription factors that control the expression of genes involved in cholesterol metabolism. The 'sterol regulatory element binding proteins' (SREBPs) are a class of transcription factors that control a feedback pathway influencing cholesterol biosynthesis and receptormediated cholesterol uptake. Recent studies have now identified the nuclear hormone receptor known as 'liver X receptor α' (LXRα) as a second major transcription factor involved in hepatic cholesterol homeostasis. LXRα appears to activate a feed-forward pathway of cholesterol catabolism. As several specific oxygenated sterolsoxysterols -have been found to be ligands for LXRα, these studies strongly implicate oxysterols as important regulators of cholesterol homeostasis.
The amount of cholesterol in animal cell membranes is tightly regulated to maintain proper cell function. Experiments performed over the past several years have shown that this regulation occurs in large part through transcription factors that control the expression of genes involved in cholesterol metabolism. The 'sterol regulatory element binding proteins' (SREBPs) are a class of transcription factors that control a feedback pathway influencing cholesterol biosynthesis and receptormediated cholesterol uptake. Recent studies have now identified the nuclear hormone receptor known as 'liver X receptor α' (LXRα) as a second major transcription factor involved in hepatic cholesterol homeostasis. LXRα appears to activate a feed-forward pathway of cholesterol catabolism. As several specific oxygenated sterolsoxysterols -have been found to be ligands for LXRα, these studies strongly implicate oxysterols as important regulators of cholesterol homeostasis.
Cholesterol homeostasis and the oxysterol hypothesis
The liver uses many homeostatic pathways to maintain optimal cellular cholesterol levels. Inside a liver cell, cholesterol can be synthesized de novo from acetate or taken up from plasma lipoproteins, which acquire cholesterol from the diet or from peripheral tissues. Lipoprotein uptake can occur either through receptormediated endocytosis, as in the case of low density lipoproteins (LDLs), or from the selective transfer of cholesterol esters into the cell, as in pathways involving the scavenger receptor BI. Hepatic cellular cholesterol has a number of possible fates: it can be esterified by acylCoA:cholesterol acyltransferases (ACATs) to form cholesterol esters; be secreted from the cell by incorporation into secreted lipoproteins or through efflux from the plasma membrane; or undergo catabolism to form bile acids. The liver represents the primary route of cholesterol excretion from the body, as both cholesterol and bile acids are secreted into the bile.
It has long been known that feeding cholesterol to animals profoundly affects liver cholesterol metabolism. Studies early in this century showed that excess dietary cholesterol markedly suppresses hepatic cholesterol biosynthesis. This inhibition occurs primarily through the downregulation of the rate-limiting enzyme in cholesterol biosynthesis, 3-hydroxy-3-methylglutaryl (HMG) CoA reductase. But whether cholesterol itself, or oxygenated derivatives of cholesterol, are the effector molecules in these regulatory processes has long been a matter of debate.
As cholesterol is insoluble in an aqueous environment and resides mainly in membranes, it has been difficult to imagine how it could function as a molecular regulator. Oxysterols, on the other hand, have emerged as potential homeostatic regulators because of their greater polarity and aqueous solubility, and because of observations dating from the 1970s that these compounds are more potent than cholesterol in downregulating cholesterol biosynthesis in cultured cells [1, 2] . A cytosolic oxysterol-binding protein was identified in the 1980s [3, 4] , but its function remains uncertain. Despite many studies, direct proof that oxysterols participate in cholesterol homeostasis has, until now, been lacking.
SREBPs: key regulators of cholesterol metabolism
In the past several years, work that originated largely in the laboratory of Brown and Goldstein has identified the SREBPs as important regulators of cholesterol biosynthesis (reviewed in [5] ; see Table 1 ). Located in the endoplasmic reticulum (ER) of cells, these membrane-bound transcription factors are activated by a proteolytic cleavage that releases the amino-terminal portion of the molecule, which subsequently localizes to the nucleus and acts as a transcription factor. The target genes include those encoding enzymes of the cholesterol biosynthesis pathway, such as HMG CoA reductase, HMG CoA synthase, farnesyl diphosphate synthase and squalene synthase, the LDL receptor gene and genes encoding enzymes involved in fatty acid synthesis and uptake, such as acetyl CoA carboxylase, fatty acid synthase and lipoprotein lipase.
There are two known members of the SREBP family: SREBP-1, which has the two splice variants SREBP-1a and SREBP-1c, and SREBP-2. In the livers of animals, SREBP-1 appears to participate more in the regulation of fatty acid synthesis and SREBP-2 in cholesterol biosynthesis. The in vivo importance of the SREBPs has been demonstrated in cultured cells, for example by studies of chinese hamster ovary (CHO) cells that are deficient in or express constitutively activated versions of SREBPs, and in transgenic animals [5, 6] .
The proteolytic activation of SREBPs is regulated by another membrane-bound protein, the 'SREBP cleavage activating protein' (SCAP) [5] . SCAP has a putative sterolsensing domain that presumably monitors the membrane sterol concentration. The current hypothesis is that changes in membrane sterol levels somehow alter the interactions between SCAP and SREBPs. When membrane sterols are low, SREBP is subsequently cleaved by two proteases, and its amino-terminus migrates to the nucleus. It is not yet known whether SCAP responds to changes in the levels of membrane cholesterol, oxysterols or both, nor is it known how SCAP senses changes in the levels of the sterols that serve as regulatory signals.
LXRa: a feed-forward regulator of cholesterol homeostasis
In addition to a feedback suppression of cholesterol biosynthesis, the hepatic response to excess cellular cholesterol also involves an upregulation of bile acid synthesis and secretion, the main pathway of cholesterol catabolism. Several in vivo studies have demonstrated that feeding cholesterol stimulates the transcription of the gene for cholesterol 7α-hydroxylase, the rate-limiting enzyme in the conversion of cholesterol to bile acids. Recent experiments have now implicated a newly identified transcription factor, LXRα, as a key regulator of this feed-forward pathway (Table 1) .
LXRα was initially identified, by cDNA cloning from human liver, as an orphan member of the nuclear hormone receptor superfamily -that is, its functions and ligands were at that point unknown [7] . Like many nuclear hormone receptors, LXRα functions as a heterodimer with the retinoid X receptor (RXR). The LXRα-RXR complex activates transcription by binding to specific DNAresponse elements composed of a direct repeat of two hexads separated by a four-nucleotide spacer. This recognition site closely resembles the binding sites for other nuclear hormone receptors.
The first clue that LXRα might be involved in cholesterol metabolism came from the discovery that a subset of R602 Current Biology, Vol 8 No 17 naturally occurring oxysterols specifically activate this transcription factor when tested in vitro at physiological concentrations [8, 9] . These potent oxysterol activators of LXRα include 24,25(S)-epoxycholesterol, which is produced from a shunt in the mevalonate synthesis pathway and is present in the liver; 22(R)-hydroxycholesterol, a product of sterol metabolism found in the adrenal glands; and 24(S)-hydroxycholesterol, which is known as 'cerebrosterol' owing to its high concentration in brain tissue extracts (Figure 1 ). Further evidence came from the observation that the promoter region of the cholesterol 7α-hydroxylase gene includes a functional LXRα response element, suggesting that LXRα has a role in the regulation of bile acid metabolism [9] . LXRα was shown to be most highly expressed in the liver, the central organ of cholesterol homeostasis, and in metabolically active tissues such as the kidney, intestine, spleen and adrenal glands [7] .
The recent generation of LXRα knockout mice by Mangelsdorf and colleagues [10] has now established a central role for LXRα in mammalian cholesterol metabolism. The homozygous mutant (LXRα -/-) mice were ostensibly healthy when fed a normal chow diet. In response to a diet rich in cholesterol, however, LXRα -/-mice failed to show the normal increase in bile acid synthesis and secretion. After a few days, massive amounts of cholesterol esters began to accumulate in their livers. Their livers increased in size and, after three months on the high-cholesterol diet, showed evidence of hepatocellular degeneration and inflammation, leading ultimately to hepatic dysfunction. As expected, the impaired bile acid synthesis was accompanied by a failure to upregulate transcription of the cholesterol 7α-hydroxylase gene. LXRα -/-mice also failed to show the normal lowering of the ratio of cholate to murocholate in the bile when fed a high-cholesterol diet. This alteration in bile acid composition normally reduces the absorption of intestinal cholesterol in wild-type animals.
The disruption in bile acid metabolism is not the only homeostatic alteration caused by the absence of LXRα. The cholesterol biosynthetic enzymes and SREBP-2 were transcriptionally upregulated in LXRα -/-mice fed a chow diet, but not in wild-type controls. Associated with this, hepatic cholesterol levels were slightly, but significantly, higher in mutant than in wild-type mice, suggesting that LXRα may also be involved in feedback suppression of cholesterol biosynthesis. In this regard, it is noteworthy that inhibitors of HMG CoA reductase have recently been shown to suppress LXRα activity, and that distinct products of mevalonate metabolism can either stimulate or inhibit LXRα activity in cultured cells [11] .
In contrast to the apparent upregulation of hepatic cholesterol biosynthesis observed in LXRα -/-mice fed a chow diet, normal suppression of cholesterol biosynthesis occurred in mutant mice fed a high-cholesterol diet, presumably via inhibition of the SREBP pathway. Unexpectedly, however, plasma LDL-cholesterol levels were increased in the LXRα -/-mice fed a high-cholesterol diet. The reason for this phenotype is currently unclear, as LDL receptor and apolipoprotein gene expression were not altered in LXRα -/-mice. Lastly, it appears that LXRα also acts to stimulate fatty acid synthesis, as transcription of the genes for SREBP-1 and for some fatty acid synthetic enzymes was found to be downregulated in LXRα -/-mice. The concomitant regulation of cholesterol biosynthesis and fatty acid synthesis is a recurring theme Dispatch R603
Figure 2
An overview of the hepatic response to increased dietary cholesterol intake. in cellular lipid biology [5] and may reflect the need for cells to adjust in parallel their membrane cholesterol and phospholipid content.
Hepatic response to dietary cholesterol
The new observations on LXRα -/-mice strongly implicate oxysterols as physiologic regulators of cholesterol homeostasis; they have also enhanced our understanding of the hepatic response to dietary cholesterol. A current perspective on this response is summarized in Figure 2 . These recent findings also, however, highlight the complexity of cellular cholesterol regulatory mechanisms and raise key questions. Are oxysterols also involved in the SCAP-mediated regulation of cholesterol biosynthesis? Which oxysterols are biologically relevant? How do cellular oxysterol levels relate to cellular cholesterol levels? How does LXRα modulate plasma LDL-cholesterol levels? Studies in progress, facilitated by the availability of probes and reagents for the newly discovered transcription factors involved in cholesterol homeostasis, are likely to provide answers to these questions.
